M G 31 (Glipizide and Metformin 2.5 mg / 250 mg)

Pill imprint M G 31 has been identified as Glipizide and metformin hydrochloride 2.5 mg / 250 mg.

Glipizide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glipizide/metformin 2.5 mg / 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glipizide and metformin hydrochloride

Imprint:

M G 31

Strength:

2.5 mg / 250 mg

Color:

White

Size:

10.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Antidiabetic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-3131

Inactive Ingredients:

croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.